Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM

Diabetes

Volumn 46, Issue 3, 1997, Pages 414-420

  Bagdade, John D ^a,e   Kelley, David E ^b   Henry, Robert R ^c   Eckel, Robert H ^d   Ritter, Mary C ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e PeaceHealth Oregon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; INSULIN; LIPOPROTEIN LIPASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; HUMAN; HYPERINSULINEMIA; INSULIN TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031053998     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.414     Document Type: Article

References (52)

1. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complication of insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Reichard P, Nilsson B-Y, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
3. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Johnson Nagel N, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS, VA CSDM Group: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Diabetes Care 18:1113-1123, 1995
4. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
5. Bierman EL: Atherogenesis in diabetes. Arteriosder Thromb 12:647-656, 1992
6. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D: Nonenzymatic glycosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283-291, 1982
7. Johnson WJ, Mahlbery FH, Rothblat GH, Phillips MC: Cholesterol transport between cells and high density lipoproteins. Biochem. Biophys Acta 1085:273-298, 1991
8. Morton RE: Free cholesterol is a potent regulator of lipid transfer function. J Biol Chem 263:12235-12241, 1988
9. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR: Persistent abnormalities in lipoprotein composition in non-insulin dependent diabetes following intensive insulin therapy. Arteriosclerosis 10:232-239, 1990
10. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC: Accelerated cholesteryl ester transfer in noninsulin dependent diabetes mellitus. Atherosclerosis 104:69-77, 1993
11. Bagdade JD, Subbaiah PV, Ritter MC: Accelerated cholesteryl ester transfer in patients with insulin dependent diabetes mellitus. Eur J Clin Invest 21:161-167, 1991
12. Dullaart FPF, Groener JEM, Dikkaschei LD, Erkelens DW, Doorenbus H: Increased cholesteryl ester transfer activity in complicated Type 1 (insulin-dependent) diabetes mellitus: its relationship with serum lipids. Diabetologia 32:14-19, 1989
13. Bhatnagar D, Durrington PN, Kumar S, Mackness MI, Dean J, Boulton AJM: Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes 44:460-465, 1995
14. Swenson TL: Transfer proteins in reverse cholesterol transport. Curr Opin Lipidol 3:67-74, 1992
15. Castro GR, Fielding CJ: Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest 75:874-882, 1985
16. Marcel YI, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, Whitlock ME, Tall AR, Milne RW: Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest 85:10-17, 1990
17. Pykalisto OJ, Smith PH, Brunzell JD: Determinants of human adipose tissue lipoprotein lipase: effect of diabetes and obesity on basal and diet-induced activity. J Clin Invest 56:1108-1117, 1975
18. Sammelt D, Tail AR: Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 260:6687-6697, 1985
19. Bagdade JD, Dunn FL, Eckel RH, Ritter MC: Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arterioscler Thromb 14:1933-1939, 1994
20. The Expert Panel: Report of the National Cholesterol Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 148:36-69, 1988
21. The DCCT Research Group: DCCT Protocol. April 1983
22. 1 lc as measured by liquid chromatography or electrophoresis. Clin Chem 27:1261-1263, 1981
23. Bagdade JD, Subbaiah PV, Ritter MC: Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 87:1259-1265, 1991
24. Bachorik PV, Albers JJ: Precipitation methods for quantification of lipoproteins. Methods Enzymol 129:78-100, 1986
25. Quig DW, Zilversmit DB: Plasma lipid transfer activity in rabbits: effects of dietary hyperlipidemias. Atherosclerosis 70:263-271, 1988
26. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadski Z, Weech PK, Whitlock ME, Tall AR, Milne RW: Distribution and concentration of cholesteryl ester transfer protein in plasma in normolipidemic subjects. J Clin Invest 85:10-17, 1990
27. Glaser DS, Yost TJ, Eckel RH: Preheparin lipolytic activities: relationship to plasma lipoprotein postheparin lipolytic activities. J Lipid Res 33:209-214, 1992
28. Goers JW, Pedersen ME, Kern PA, Ong J, Schotz MC: An enzyme-linked immunoassay for lipoprotein lipase. Anal Blochem 166:27-35, 1987
29. Selam JL, Slingeneyer A, Hedon B, Mares P, Beraud JJ, Mirouze J: Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes. Diabetes Care 6:105-111, 1983
30. Tall AR: Plasma lipid transfer proteins. J Lipid Res 34:1253-1274, 1993
31. Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M: Accelerated cholesteryl ester transfer in dyslipidemic plasma: role of cholesteryl ester transfer protein. J Clin Invest 79:1217-1225, 1987
32. Mann GJ, Yen FT, Grant AM, Bihain BE: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 88:2059-2066, 1991
33. Tall AR: Cholesteryl ester transfer protein. J Lipid Res 27:361-367, 1986
34. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchoir GW: Severe atherosclerosis in transgenic mice expression simian cholesteryl ester protein. Nature 304:73-75, 1993
35. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Tajata K, Maruhama Y, Mabuchi H, Tall AR: Increased high-density lipoproteins levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323:1234-1238, 1990
36. Quintao ELR: Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Atheroscterosis 116:1-14, 1995
37. Hayek T, Masucei-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR: Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 96:2071-2074, 1995
38. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, et al.: Atherosclerotic disease in marked hyperal-phalipoproteinemia-combined reduction of cholesteryl ester transfer protein and hepatic triglyceride. Arterioscler Thromb Vasc Biol 15:1849-1856, 1995
39. Kahri J, Syvanne M, Taskinen M-R: Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary disease. Metabolism 43:1498-1502, 1994
40. Barter P, Rye KA: Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin Exp Pharmacol Physiol 21:663-672, 1994
41. Nikkila EA, Huttunen JK, Enholm C: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 26:11-21, 1977
42. Duckworth WC, Saudek CD: Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 41:647-661, 1992
43. Bagdade JD, Porte D Jr, Bierman EL: Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity. J Lab Clin Med 83:563-569, 1974
44. Ruotolo G, Parlavecchia M, Taskinen MR, Galimberti G, Zoppo A, Le N-A, Ragogna F, Micossi P, Pozza G: Normalization of lipoprotein composition by intraperitoneal insulin in IDDM: role of increased hepatic lipase activity. Diabetes Care 17:6-12, 1994
45. Tornvall P, Olivercrona G, Karpe F, Hamsten A, Olivercrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15:1086-1093, 1995
46. Cummings MH, Watts GF, Pag C, Umpleby M, Hennessy TR, Naoumova R, Sonksen PH: Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study. Clin Sci 88:225-233, 1995
47. Ruotolo G, Micossi P, Galimberti G, Librenti MC, Peterella G, Marcovina S, Pozza G, Howard BV: Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type 1 diabetes. Metabolism 39:598-604, 1990
48. Ritter MC, Bagdade JD: Contribution of glycemic control, endogenous lipoproteins and cholesteryl ester transfer protein to accelerated cholesteryl ester transfer in IDDM. Eur J Clin Invest 24:607-614, 1994
49. Lagrost L: Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1215:209-236, 1994
50. Morton RE, Steinbrunner JV: Determination of lipid transfer inhibitory protein activity in human lipoprotein-deftcient plasma. Arterioscler Thromb 13:1843-1851, 1993
51. Georgopoulos A, Saudek C: Normalization of composition of triglyceriderich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system. Diabetes Care 15:19-26, 1992
52. Floren C-H, Nilsson A: Insulin stimulates the uptake of chylomicron remnants in cultured rat hepatocytes. Eur J Clin Invest 18:226-232, 1988